Global Angiotensin Receptor Antagonists Market Insights, Forecast to 2029
This report presents an overview of global market for Angiotensin Receptor Antagonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Angiotensin Receptor Antagonists, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Angiotensin Receptor Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Angiotensin Receptor Antagonists sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Angiotensin Receptor Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Angiotensin Receptor Antagonists sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Angiotensin Receptor Antagonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Angiotensin Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Angiotensin Receptor Antagonists sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Angiotensin Receptor Antagonists, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Angiotensin Receptor Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Angiotensin Receptor Antagonists sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Angiotensin Receptor Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Angiotensin Receptor Antagonists sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc.
By Company
- Pfizer
- Novartis
- Merck
- Astra Zeneca
- Jhonson and Johnson
- Eli Lilly
- Sanofi
- Bristol-Myers Squibb
- Bayer
- GSK
- Teva Pharmaceutical
- Valsartan
- Telmisartan
- Losartan
- Irbesartan
- Azilsartan
- Olmesartan
- Hypertension
- Cardiovascular Diseases
- Kidney Diseases
- Other
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Angiotensin Receptor Antagonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Angiotensin Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Angiotensin Receptor Antagonists sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Angiotensin Receptor Antagonists Product Introduction
1.2 Market by Type
1.2.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Market by Application
1.3.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Angiotensin Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.2 Global Angiotensin Receptor Antagonists Revenue by Region
2.2.1 Global Angiotensin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Angiotensin Receptor Antagonists Revenue by Region (2018-2023)
2.2.3 Global Angiotensin Receptor Antagonists Revenue by Region (2024-2029)
2.2.4 Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2018-2029)
2.3 Global Angiotensin Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.4 Global Angiotensin Receptor Antagonists Sales by Region
2.4.1 Global Angiotensin Receptor Antagonists Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Angiotensin Receptor Antagonists Sales by Region (2018-2023)
2.4.3 Global Angiotensin Receptor Antagonists Sales by Region (2024-2029)
2.4.4 Global Angiotensin Receptor Antagonists Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Angiotensin Receptor Antagonists Sales by Manufacturers
3.1.1 Global Angiotensin Receptor Antagonists Sales by Manufacturers (2018-2023)
3.1.2 Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Angiotensin Receptor Antagonists in 2022
3.2 Global Angiotensin Receptor Antagonists Revenue by Manufacturers
3.2.1 Global Angiotensin Receptor Antagonists Revenue by Manufacturers (2018-2023)
3.2.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Angiotensin Receptor Antagonists Revenue in 2022
3.3 Global Key Players of Angiotensin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Angiotensin Receptor Antagonists Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Angiotensin Receptor Antagonists, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Angiotensin Receptor Antagonists, Product Offered and Application
3.8 Global Key Manufacturers of Angiotensin Receptor Antagonists, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Angiotensin Receptor Antagonists Sales by Type
4.1.1 Global Angiotensin Receptor Antagonists Historical Sales by Type (2018-2023)
4.1.2 Global Angiotensin Receptor Antagonists Forecasted Sales by Type (2024-2029)
4.1.3 Global Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
4.2 Global Angiotensin Receptor Antagonists Revenue by Type
4.2.1 Global Angiotensin Receptor Antagonists Historical Revenue by Type (2018-2023)
4.2.2 Global Angiotensin Receptor Antagonists Forecasted Revenue by Type (2024-2029)
4.2.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
4.3 Global Angiotensin Receptor Antagonists Price by Type
4.3.1 Global Angiotensin Receptor Antagonists Price by Type (2018-2023)
4.3.2 Global Angiotensin Receptor Antagonists Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Angiotensin Receptor Antagonists Sales by Application
5.1.1 Global Angiotensin Receptor Antagonists Historical Sales by Application (2018-2023)
5.1.2 Global Angiotensin Receptor Antagonists Forecasted Sales by Application (2024-2029)
5.1.3 Global Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
5.2 Global Angiotensin Receptor Antagonists Revenue by Application
5.2.1 Global Angiotensin Receptor Antagonists Historical Revenue by Application (2018-2023)
5.2.2 Global Angiotensin Receptor Antagonists Forecasted Revenue by Application (2024-2029)
5.2.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
5.3 Global Angiotensin Receptor Antagonists Price by Application
5.3.1 Global Angiotensin Receptor Antagonists Price by Application (2018-2023)
5.3.2 Global Angiotensin Receptor Antagonists Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Angiotensin Receptor Antagonists Market Size by Type
6.1.1 US & Canada Angiotensin Receptor Antagonists Sales by Type (2018-2029)
6.1.2 US & Canada Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
6.2 US & Canada Angiotensin Receptor Antagonists Market Size by Application
6.2.1 US & Canada Angiotensin Receptor Antagonists Sales by Application (2018-2029)
6.2.2 US & Canada Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
6.3 US & Canada Angiotensin Receptor Antagonists Market Size by Country
6.3.1 US & Canada Angiotensin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Angiotensin Receptor Antagonists Sales by Country (2018-2029)
6.3.3 US & Canada Angiotensin Receptor Antagonists Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Angiotensin Receptor Antagonists Market Size by Type
7.1.1 Europe Angiotensin Receptor Antagonists Sales by Type (2018-2029)
7.1.2 Europe Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
7.2 Europe Angiotensin Receptor Antagonists Market Size by Application
7.2.1 Europe Angiotensin Receptor Antagonists Sales by Application (2018-2029)
7.2.2 Europe Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
7.3 Europe Angiotensin Receptor Antagonists Market Size by Country
7.3.1 Europe Angiotensin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Angiotensin Receptor Antagonists Sales by Country (2018-2029)
7.3.3 Europe Angiotensin Receptor Antagonists Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Angiotensin Receptor Antagonists Market Size
8.1.1 China Angiotensin Receptor Antagonists Sales (2018-2029)
8.1.2 China Angiotensin Receptor Antagonists Revenue (2018-2029)
8.2 China Angiotensin Receptor Antagonists Market Size by Application
8.2.1 China Angiotensin Receptor Antagonists Sales by Application (2018-2029)
8.2.2 China Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Angiotensin Receptor Antagonists Market Size by Type
9.1.1 Asia Angiotensin Receptor Antagonists Sales by Type (2018-2029)
9.1.2 Asia Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
9.2 Asia Angiotensin Receptor Antagonists Market Size by Application
9.2.1 Asia Angiotensin Receptor Antagonists Sales by Application (2018-2029)
9.2.2 Asia Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
9.3 Asia Angiotensin Receptor Antagonists Sales by Region
9.3.1 Asia Angiotensin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Angiotensin Receptor Antagonists Revenue by Region (2018-2029)
9.3.3 Asia Angiotensin Receptor Antagonists Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Market Size by Type
10.1.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Market Size by Application
10.2.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country
10.3.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Novartis Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Merck Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Information
11.4.2 Astra Zeneca Overview
11.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Astra Zeneca Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astra Zeneca Recent Developments
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Information
11.5.2 Jhonson and Johnson Overview
11.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jhonson and Johnson Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Eli Lilly Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Sanofi Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Overview
11.9.3 Bayer Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Bayer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 GSK
11.10.1 GSK Company Information
11.10.2 GSK Overview
11.10.3 GSK Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 GSK Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Recent Developments
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Information
11.11.2 Teva Pharmaceutical Overview
11.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceutical Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Angiotensin Receptor Antagonists Industry Chain Analysis
12.2 Angiotensin Receptor Antagonists Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Angiotensin Receptor Antagonists Production Mode & Process
12.4 Angiotensin Receptor Antagonists Sales and Marketing
12.4.1 Angiotensin Receptor Antagonists Sales Channels
12.4.2 Angiotensin Receptor Antagonists Distributors
12.5 Angiotensin Receptor Antagonists Customers
13 MARKET DYNAMICS
13.1 Angiotensin Receptor Antagonists Industry Trends
13.2 Angiotensin Receptor Antagonists Market Drivers
13.3 Angiotensin Receptor Antagonists Market Challenges
13.4 Angiotensin Receptor Antagonists Market Restraints
14 KEY FINDINGS IN THE GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Angiotensin Receptor Antagonists Product Introduction
1.2 Market by Type
1.2.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Market by Application
1.3.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Angiotensin Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.2 Global Angiotensin Receptor Antagonists Revenue by Region
2.2.1 Global Angiotensin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Angiotensin Receptor Antagonists Revenue by Region (2018-2023)
2.2.3 Global Angiotensin Receptor Antagonists Revenue by Region (2024-2029)
2.2.4 Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2018-2029)
2.3 Global Angiotensin Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.4 Global Angiotensin Receptor Antagonists Sales by Region
2.4.1 Global Angiotensin Receptor Antagonists Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Angiotensin Receptor Antagonists Sales by Region (2018-2023)
2.4.3 Global Angiotensin Receptor Antagonists Sales by Region (2024-2029)
2.4.4 Global Angiotensin Receptor Antagonists Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Angiotensin Receptor Antagonists Sales by Manufacturers
3.1.1 Global Angiotensin Receptor Antagonists Sales by Manufacturers (2018-2023)
3.1.2 Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Angiotensin Receptor Antagonists in 2022
3.2 Global Angiotensin Receptor Antagonists Revenue by Manufacturers
3.2.1 Global Angiotensin Receptor Antagonists Revenue by Manufacturers (2018-2023)
3.2.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Angiotensin Receptor Antagonists Revenue in 2022
3.3 Global Key Players of Angiotensin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Angiotensin Receptor Antagonists Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Angiotensin Receptor Antagonists, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Angiotensin Receptor Antagonists, Product Offered and Application
3.8 Global Key Manufacturers of Angiotensin Receptor Antagonists, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Angiotensin Receptor Antagonists Sales by Type
4.1.1 Global Angiotensin Receptor Antagonists Historical Sales by Type (2018-2023)
4.1.2 Global Angiotensin Receptor Antagonists Forecasted Sales by Type (2024-2029)
4.1.3 Global Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
4.2 Global Angiotensin Receptor Antagonists Revenue by Type
4.2.1 Global Angiotensin Receptor Antagonists Historical Revenue by Type (2018-2023)
4.2.2 Global Angiotensin Receptor Antagonists Forecasted Revenue by Type (2024-2029)
4.2.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
4.3 Global Angiotensin Receptor Antagonists Price by Type
4.3.1 Global Angiotensin Receptor Antagonists Price by Type (2018-2023)
4.3.2 Global Angiotensin Receptor Antagonists Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Angiotensin Receptor Antagonists Sales by Application
5.1.1 Global Angiotensin Receptor Antagonists Historical Sales by Application (2018-2023)
5.1.2 Global Angiotensin Receptor Antagonists Forecasted Sales by Application (2024-2029)
5.1.3 Global Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
5.2 Global Angiotensin Receptor Antagonists Revenue by Application
5.2.1 Global Angiotensin Receptor Antagonists Historical Revenue by Application (2018-2023)
5.2.2 Global Angiotensin Receptor Antagonists Forecasted Revenue by Application (2024-2029)
5.2.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
5.3 Global Angiotensin Receptor Antagonists Price by Application
5.3.1 Global Angiotensin Receptor Antagonists Price by Application (2018-2023)
5.3.2 Global Angiotensin Receptor Antagonists Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Angiotensin Receptor Antagonists Market Size by Type
6.1.1 US & Canada Angiotensin Receptor Antagonists Sales by Type (2018-2029)
6.1.2 US & Canada Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
6.2 US & Canada Angiotensin Receptor Antagonists Market Size by Application
6.2.1 US & Canada Angiotensin Receptor Antagonists Sales by Application (2018-2029)
6.2.2 US & Canada Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
6.3 US & Canada Angiotensin Receptor Antagonists Market Size by Country
6.3.1 US & Canada Angiotensin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Angiotensin Receptor Antagonists Sales by Country (2018-2029)
6.3.3 US & Canada Angiotensin Receptor Antagonists Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Angiotensin Receptor Antagonists Market Size by Type
7.1.1 Europe Angiotensin Receptor Antagonists Sales by Type (2018-2029)
7.1.2 Europe Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
7.2 Europe Angiotensin Receptor Antagonists Market Size by Application
7.2.1 Europe Angiotensin Receptor Antagonists Sales by Application (2018-2029)
7.2.2 Europe Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
7.3 Europe Angiotensin Receptor Antagonists Market Size by Country
7.3.1 Europe Angiotensin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Angiotensin Receptor Antagonists Sales by Country (2018-2029)
7.3.3 Europe Angiotensin Receptor Antagonists Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Angiotensin Receptor Antagonists Market Size
8.1.1 China Angiotensin Receptor Antagonists Sales (2018-2029)
8.1.2 China Angiotensin Receptor Antagonists Revenue (2018-2029)
8.2 China Angiotensin Receptor Antagonists Market Size by Application
8.2.1 China Angiotensin Receptor Antagonists Sales by Application (2018-2029)
8.2.2 China Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Angiotensin Receptor Antagonists Market Size by Type
9.1.1 Asia Angiotensin Receptor Antagonists Sales by Type (2018-2029)
9.1.2 Asia Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
9.2 Asia Angiotensin Receptor Antagonists Market Size by Application
9.2.1 Asia Angiotensin Receptor Antagonists Sales by Application (2018-2029)
9.2.2 Asia Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
9.3 Asia Angiotensin Receptor Antagonists Sales by Region
9.3.1 Asia Angiotensin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Angiotensin Receptor Antagonists Revenue by Region (2018-2029)
9.3.3 Asia Angiotensin Receptor Antagonists Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Market Size by Type
10.1.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Market Size by Application
10.2.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country
10.3.1 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Novartis Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Merck Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Information
11.4.2 Astra Zeneca Overview
11.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Astra Zeneca Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astra Zeneca Recent Developments
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Information
11.5.2 Jhonson and Johnson Overview
11.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jhonson and Johnson Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Eli Lilly Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Sanofi Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Overview
11.9.3 Bayer Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Bayer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 GSK
11.10.1 GSK Company Information
11.10.2 GSK Overview
11.10.3 GSK Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 GSK Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Recent Developments
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Information
11.11.2 Teva Pharmaceutical Overview
11.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceutical Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Angiotensin Receptor Antagonists Industry Chain Analysis
12.2 Angiotensin Receptor Antagonists Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Angiotensin Receptor Antagonists Production Mode & Process
12.4 Angiotensin Receptor Antagonists Sales and Marketing
12.4.1 Angiotensin Receptor Antagonists Sales Channels
12.4.2 Angiotensin Receptor Antagonists Distributors
12.5 Angiotensin Receptor Antagonists Customers
13 MARKET DYNAMICS
13.1 Angiotensin Receptor Antagonists Industry Trends
13.2 Angiotensin Receptor Antagonists Market Drivers
13.3 Angiotensin Receptor Antagonists Market Challenges
13.4 Angiotensin Receptor Antagonists Market Restraints
14 KEY FINDINGS IN THE GLOBAL ANGIOTENSIN RECEPTOR ANTAGONISTS STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Valsartan
Table 3. Major Manufacturers of Telmisartan
Table 4. Major Manufacturers of Losartan
Table 5. Major Manufacturers of Irbesartan
Table 6. Major Manufacturers of Azilsartan
Table 7. Major Manufacturers of Olmesartan
Table 8. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Angiotensin Receptor Antagonists Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Angiotensin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2018-2023)
Table 13. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2024-2029)
Table 14. Global Angiotensin Receptor Antagonists Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Angiotensin Receptor Antagonists Sales by Region (2018-2023) & (K MT)
Table 16. Global Angiotensin Receptor Antagonists Sales by Region (2024-2029) & (K MT)
Table 17. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2018-2023)
Table 18. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2024-2029)
Table 19. Global Angiotensin Receptor Antagonists Sales by Manufacturers (2018-2023) & (K MT)
Table 20. Global Angiotensin Receptor Antagonists Sales Share by Manufacturers (2018-2023)
Table 21. Global Angiotensin Receptor Antagonists Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Angiotensin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2023
Table 24. Angiotensin Receptor Antagonists Price by Manufacturers 2018-2023 (USD/MT)
Table 25. Global Angiotensin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2022)
Table 27. Global Key Manufacturers of Angiotensin Receptor Antagonists, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Angiotensin Receptor Antagonists, Product Offered and Application
Table 29. Global Key Manufacturers of Angiotensin Receptor Antagonists, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 32. Global Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 33. Global Angiotensin Receptor Antagonists Sales Share by Type (2018-2023)
Table 34. Global Angiotensin Receptor Antagonists Sales Share by Type (2024-2029)
Table 35. Global Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Angiotensin Receptor Antagonists Revenue Share by Type (2018-2023)
Table 38. Global Angiotensin Receptor Antagonists Revenue Share by Type (2024-2029)
Table 39. Angiotensin Receptor Antagonists Price by Type (2018-2023) & (USD/MT)
Table 40. Global Angiotensin Receptor Antagonists Price Forecast by Type (2024-2029) & (USD/MT)
Table 41. Global Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 42. Global Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 43. Global Angiotensin Receptor Antagonists Sales Share by Application (2018-2023)
Table 44. Global Angiotensin Receptor Antagonists Sales Share by Application (2024-2029)
Table 45. Global Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Angiotensin Receptor Antagonists Revenue Share by Application (2018-2023)
Table 48. Global Angiotensin Receptor Antagonists Revenue Share by Application (2024-2029)
Table 49. Angiotensin Receptor Antagonists Price by Application (2018-2023) & (USD/MT)
Table 50. Global Angiotensin Receptor Antagonists Price Forecast by Application (2024-2029) & (USD/MT)
Table 51. US & Canada Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 52. US & Canada Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 53. US & Canada Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 56. US & Canada Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 57. US & Canada Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Angiotensin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Angiotensin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Angiotensin Receptor Antagonists Sales by Country (2018-2023) & (K MT)
Table 63. US & Canada Angiotensin Receptor Antagonists Sales by Country (2024-2029) & (K MT)
Table 64. Europe Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 65. Europe Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 66. Europe Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 69. Europe Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 70. Europe Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Angiotensin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Angiotensin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Angiotensin Receptor Antagonists Sales by Country (2018-2023) & (K MT)
Table 76. Europe Angiotensin Receptor Antagonists Sales by Country (2024-2029) & (K MT)
Table 77. China Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 78. China Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 79. China Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 82. China Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 83. China Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 86. Asia Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 87. Asia Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 90. Asia Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 91. Asia Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Angiotensin Receptor Antagonists Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Angiotensin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Angiotensin Receptor Antagonists Sales by Region (2018-2023) & (K MT)
Table 97. Asia Angiotensin Receptor Antagonists Sales by Region (2024-2029) & (K MT)
Table 98. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 99. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 100. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 103. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 104. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country (2018-2023) & (K MT)
Table 110. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country (2024-2029) & (K MT)
Table 111. Pfizer Company Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 114. Pfizer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Novartis Company Information
Table 117. Novartis Description and Major Businesses
Table 118. Novartis Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 119. Novartis Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Novartis Recent Developments
Table 121. Merck Company Information
Table 122. Merck Description and Major Businesses
Table 123. Merck Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 124. Merck Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Merck Recent Developments
Table 126. Astra Zeneca Company Information
Table 127. Astra Zeneca Description and Major Businesses
Table 128. Astra Zeneca Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 129. Astra Zeneca Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Astra Zeneca Recent Developments
Table 131. Jhonson and Johnson Company Information
Table 132. Jhonson and Johnson Description and Major Businesses
Table 133. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 134. Jhonson and Johnson Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Jhonson and Johnson Recent Developments
Table 136. Eli Lilly Company Information
Table 137. Eli Lilly Description and Major Businesses
Table 138. Eli Lilly Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 139. Eli Lilly Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Eli Lilly Recent Developments
Table 141. Sanofi Company Information
Table 142. Sanofi Description and Major Businesses
Table 143. Sanofi Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 144. Sanofi Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sanofi Recent Developments
Table 146. Bristol-Myers Squibb Company Information
Table 147. Bristol-Myers Squibb Description and Major Businesses
Table 148. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 149. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bristol-Myers Squibb Recent Developments
Table 151. Bayer Company Information
Table 152. Bayer Description and Major Businesses
Table 153. Bayer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 154. Bayer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Bayer Recent Developments
Table 156. GSK Company Information
Table 157. GSK Description and Major Businesses
Table 158. GSK Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 159. GSK Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. GSK Recent Developments
Table 161. Teva Pharmaceutical Company Information
Table 162. Teva Pharmaceutical Description and Major Businesses
Table 163. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 164. Teva Pharmaceutical Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Teva Pharmaceutical Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Angiotensin Receptor Antagonists Distributors List
Table 169. Angiotensin Receptor Antagonists Customers List
Table 170. Angiotensin Receptor Antagonists Market Trends
Table 171. Angiotensin Receptor Antagonists Market Drivers
Table 172. Angiotensin Receptor Antagonists Market Challenges
Table 173. Angiotensin Receptor Antagonists Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
Table 1. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Valsartan
Table 3. Major Manufacturers of Telmisartan
Table 4. Major Manufacturers of Losartan
Table 5. Major Manufacturers of Irbesartan
Table 6. Major Manufacturers of Azilsartan
Table 7. Major Manufacturers of Olmesartan
Table 8. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Angiotensin Receptor Antagonists Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Angiotensin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2018-2023)
Table 13. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2024-2029)
Table 14. Global Angiotensin Receptor Antagonists Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Angiotensin Receptor Antagonists Sales by Region (2018-2023) & (K MT)
Table 16. Global Angiotensin Receptor Antagonists Sales by Region (2024-2029) & (K MT)
Table 17. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2018-2023)
Table 18. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2024-2029)
Table 19. Global Angiotensin Receptor Antagonists Sales by Manufacturers (2018-2023) & (K MT)
Table 20. Global Angiotensin Receptor Antagonists Sales Share by Manufacturers (2018-2023)
Table 21. Global Angiotensin Receptor Antagonists Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Angiotensin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2023
Table 24. Angiotensin Receptor Antagonists Price by Manufacturers 2018-2023 (USD/MT)
Table 25. Global Angiotensin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2022)
Table 27. Global Key Manufacturers of Angiotensin Receptor Antagonists, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Angiotensin Receptor Antagonists, Product Offered and Application
Table 29. Global Key Manufacturers of Angiotensin Receptor Antagonists, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 32. Global Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 33. Global Angiotensin Receptor Antagonists Sales Share by Type (2018-2023)
Table 34. Global Angiotensin Receptor Antagonists Sales Share by Type (2024-2029)
Table 35. Global Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Angiotensin Receptor Antagonists Revenue Share by Type (2018-2023)
Table 38. Global Angiotensin Receptor Antagonists Revenue Share by Type (2024-2029)
Table 39. Angiotensin Receptor Antagonists Price by Type (2018-2023) & (USD/MT)
Table 40. Global Angiotensin Receptor Antagonists Price Forecast by Type (2024-2029) & (USD/MT)
Table 41. Global Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 42. Global Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 43. Global Angiotensin Receptor Antagonists Sales Share by Application (2018-2023)
Table 44. Global Angiotensin Receptor Antagonists Sales Share by Application (2024-2029)
Table 45. Global Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Angiotensin Receptor Antagonists Revenue Share by Application (2018-2023)
Table 48. Global Angiotensin Receptor Antagonists Revenue Share by Application (2024-2029)
Table 49. Angiotensin Receptor Antagonists Price by Application (2018-2023) & (USD/MT)
Table 50. Global Angiotensin Receptor Antagonists Price Forecast by Application (2024-2029) & (USD/MT)
Table 51. US & Canada Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 52. US & Canada Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 53. US & Canada Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 56. US & Canada Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 57. US & Canada Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Angiotensin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Angiotensin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Angiotensin Receptor Antagonists Sales by Country (2018-2023) & (K MT)
Table 63. US & Canada Angiotensin Receptor Antagonists Sales by Country (2024-2029) & (K MT)
Table 64. Europe Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 65. Europe Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 66. Europe Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 69. Europe Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 70. Europe Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Angiotensin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Angiotensin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Angiotensin Receptor Antagonists Sales by Country (2018-2023) & (K MT)
Table 76. Europe Angiotensin Receptor Antagonists Sales by Country (2024-2029) & (K MT)
Table 77. China Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 78. China Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 79. China Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 82. China Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 83. China Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 86. Asia Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 87. Asia Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 90. Asia Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 91. Asia Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Angiotensin Receptor Antagonists Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Angiotensin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Angiotensin Receptor Antagonists Sales by Region (2018-2023) & (K MT)
Table 97. Asia Angiotensin Receptor Antagonists Sales by Region (2024-2029) & (K MT)
Table 98. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Type (2018-2023) & (K MT)
Table 99. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Type (2024-2029) & (K MT)
Table 100. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Application (2018-2023) & (K MT)
Table 103. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Application (2024-2029) & (K MT)
Table 104. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country (2018-2023) & (K MT)
Table 110. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales by Country (2024-2029) & (K MT)
Table 111. Pfizer Company Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 114. Pfizer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Novartis Company Information
Table 117. Novartis Description and Major Businesses
Table 118. Novartis Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 119. Novartis Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Novartis Recent Developments
Table 121. Merck Company Information
Table 122. Merck Description and Major Businesses
Table 123. Merck Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 124. Merck Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Merck Recent Developments
Table 126. Astra Zeneca Company Information
Table 127. Astra Zeneca Description and Major Businesses
Table 128. Astra Zeneca Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 129. Astra Zeneca Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Astra Zeneca Recent Developments
Table 131. Jhonson and Johnson Company Information
Table 132. Jhonson and Johnson Description and Major Businesses
Table 133. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 134. Jhonson and Johnson Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Jhonson and Johnson Recent Developments
Table 136. Eli Lilly Company Information
Table 137. Eli Lilly Description and Major Businesses
Table 138. Eli Lilly Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 139. Eli Lilly Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Eli Lilly Recent Developments
Table 141. Sanofi Company Information
Table 142. Sanofi Description and Major Businesses
Table 143. Sanofi Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 144. Sanofi Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sanofi Recent Developments
Table 146. Bristol-Myers Squibb Company Information
Table 147. Bristol-Myers Squibb Description and Major Businesses
Table 148. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 149. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bristol-Myers Squibb Recent Developments
Table 151. Bayer Company Information
Table 152. Bayer Description and Major Businesses
Table 153. Bayer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 154. Bayer Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Bayer Recent Developments
Table 156. GSK Company Information
Table 157. GSK Description and Major Businesses
Table 158. GSK Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 159. GSK Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. GSK Recent Developments
Table 161. Teva Pharmaceutical Company Information
Table 162. Teva Pharmaceutical Description and Major Businesses
Table 163. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 164. Teva Pharmaceutical Angiotensin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Teva Pharmaceutical Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Angiotensin Receptor Antagonists Distributors List
Table 169. Angiotensin Receptor Antagonists Customers List
Table 170. Angiotensin Receptor Antagonists Market Trends
Table 171. Angiotensin Receptor Antagonists Market Drivers
Table 172. Angiotensin Receptor Antagonists Market Challenges
Table 173. Angiotensin Receptor Antagonists Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Angiotensin Receptor Antagonists Product Picture
Figure 2. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Angiotensin Receptor Antagonists Market Share by Type in 2022 & 2029
Figure 4. Valsartan Product Picture
Figure 5. Telmisartan Product Picture
Figure 6. Losartan Product Picture
Figure 7. Irbesartan Product Picture
Figure 8. Azilsartan Product Picture
Figure 9. Olmesartan Product Picture
Figure 10. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Angiotensin Receptor Antagonists Market Share by Application in 2022 & 2029
Figure 12. Hypertension
Figure 13. Cardiovascular Diseases
Figure 14. Kidney Diseases
Figure 15. Other
Figure 16. Angiotensin Receptor Antagonists Report Years Considered
Figure 17. Global Angiotensin Receptor Antagonists Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Angiotensin Receptor Antagonists Revenue 2018-2029 (US$ Million)
Figure 19. Global Angiotensin Receptor Antagonists Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2018-2029)
Figure 21. Global Angiotensin Receptor Antagonists Sales 2018-2029 ((K MT)
Figure 22. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 24. US & Canada Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 26. Europe Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 28. China Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 30. Asia (excluding China) Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 32. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Angiotensin Receptor Antagonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Angiotensin Receptor Antagonists in the World: Market Share by Angiotensin Receptor Antagonists Revenue in 2022
Figure 35. Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 37. Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 38. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 39. Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Angiotensin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 45. US & Canada Angiotensin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 46. U.S. Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 49. Europe Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 50. Europe Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 51. Europe Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 52. Europe Angiotensin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 53. Europe Angiotensin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 54. Germany Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 55. France Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 59. China Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 60. China Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 61. China Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 62. China Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 63. Asia Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 64. Asia Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 65. Asia Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 66. Asia Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 67. Asia Angiotensin Receptor Antagonists Revenue Share by Region (2018-2029)
Figure 68. Asia Angiotensin Receptor Antagonists Sales Share by Region (2018-2029)
Figure 69. Japan Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 73. India Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 80. Brazil Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 85. Angiotensin Receptor Antagonists Value Chain
Figure 86. Angiotensin Receptor Antagonists Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Figure 1. Angiotensin Receptor Antagonists Product Picture
Figure 2. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Angiotensin Receptor Antagonists Market Share by Type in 2022 & 2029
Figure 4. Valsartan Product Picture
Figure 5. Telmisartan Product Picture
Figure 6. Losartan Product Picture
Figure 7. Irbesartan Product Picture
Figure 8. Azilsartan Product Picture
Figure 9. Olmesartan Product Picture
Figure 10. Global Angiotensin Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Angiotensin Receptor Antagonists Market Share by Application in 2022 & 2029
Figure 12. Hypertension
Figure 13. Cardiovascular Diseases
Figure 14. Kidney Diseases
Figure 15. Other
Figure 16. Angiotensin Receptor Antagonists Report Years Considered
Figure 17. Global Angiotensin Receptor Antagonists Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Angiotensin Receptor Antagonists Revenue 2018-2029 (US$ Million)
Figure 19. Global Angiotensin Receptor Antagonists Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2018-2029)
Figure 21. Global Angiotensin Receptor Antagonists Sales 2018-2029 ((K MT)
Figure 22. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 24. US & Canada Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 26. Europe Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 28. China Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 30. Asia (excluding China) Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales YoY (2018-2029) & (K MT)
Figure 32. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Angiotensin Receptor Antagonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Angiotensin Receptor Antagonists in the World: Market Share by Angiotensin Receptor Antagonists Revenue in 2022
Figure 35. Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 37. Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 38. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 39. Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Angiotensin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 45. US & Canada Angiotensin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 46. U.S. Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 49. Europe Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 50. Europe Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 51. Europe Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 52. Europe Angiotensin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 53. Europe Angiotensin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 54. Germany Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 55. France Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 59. China Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 60. China Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 61. China Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 62. China Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 63. Asia Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 64. Asia Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 65. Asia Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 66. Asia Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 67. Asia Angiotensin Receptor Antagonists Revenue Share by Region (2018-2029)
Figure 68. Asia Angiotensin Receptor Antagonists Sales Share by Region (2018-2029)
Figure 69. Japan Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 73. India Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Angiotensin Receptor Antagonists Sales Share by Country (2018-2029)
Figure 80. Brazil Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Angiotensin Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 85. Angiotensin Receptor Antagonists Value Chain
Figure 86. Angiotensin Receptor Antagonists Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
